A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Metabolic Dysfunction-Associated Steatohepatitis · Non-alcoholic Fatty Liver Disease

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

GSK Investigational Site, Chandler, Arizona, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Anita Kohli)
GSK Investigational Site, Mesa, Arizona, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Ann Moore)
GSK Investigational Site, Tucson, Arizona, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Aimee Bachelier)
GSK Investigational Site, Fresno, California, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Muhammad Sheikh)
GSK Investigational Site, Lancaster, California, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Jatinder Pruthi)
GSK Investigational Site, Pasadena, California, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Edward Mena)
GSK Investigational Site, Rialto, California, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Zeid Kayali)
GSK Investigational Site, Santa Maria, California, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Keval Shah)
GSK Investigational Site, Miami, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Lazaro M Garcia)
GSK Investigational Site, Viera, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Rosemary Laird)
GSK Investigational Site, Marietta, Georgia, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Aasim Sheikh)
GSK Investigational Site, Baltimore, Maryland, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Paul Thuluvath)
GSK Investigational Site, Kansas City, Missouri, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Bradley Freilich)
GSK Investigational Site, New York, New York, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Frances Lee)
GSK Investigational Site, Fayetteville, North Carolina, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (John Poulos)
GSK Investigational Site, Wilson, North Carolina, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Mitchell Mahmoud)
GSK Investigational Site, Austin, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Nomita Kim)
GSK Investigational Site, Austin, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Rohit Puskoor)
GSK Investigational Site, Austin, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Carmen Landaverde)
GSK Investigational Site, Dallas, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Parvez Mantry)
GSK Investigational Site, Georgetown, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Nirupama Jerome)
GSK Investigational Site, Houston, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Prasun Jalal)
GSK Investigational Site, Houston, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Joseph Galati)
GSK Investigational Site, Houston, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (David Huang)
GSK Investigational Site, Pasadena, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Rukan Daccak)
GSK Investigational Site, Pearland, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Jignesh Shah)
GSK Investigational Site, San Antonio, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Eric Lawitz)
GSK Investigational Site, San Antonio, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Daniel Santillano)
GSK Investigational Site, Waco, Texas, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Gregg Lucksinger)
GSK Investigational Site, Richmond, Virginia, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Michael Fuchs)

צפייה במקור ב־ClinicalTrials.gov

ניסויים דומים

ניסויים נוספים שמגייסים כעת ועשויים להיות רלוונטיים לפי מצב רפואי, טיפול, שלב או מיקום

Digoxin In NASH (CODIN)

NASH · NAFLD · MASH - Metabolic Dysfunction-Associated Steatohepatitis

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

New Haven, United States · New Haven, United States

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Obesity · Liver Diseases · Liver Fibrosis

חו"ל (דורש נסיעה)מגייס משתתפים

Boston, United States · Morgantown, United States

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

Nonalcoholic Steatohepatitis (NASH) · Metabolic Dysfunction-Associated Steatohepatitis (MASH) · Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

Columbia, United States

Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients

Metabolic Syndrome X · Fatty Liver · MASH - Metabolic Dysfunction-Associated Steatohepatitis

חו"ל (דורש נסיעה)מגייס משתתפים

Angers, France · Clichy, France